Synthesis and biological evaluation of inhibitors of thymidine monophosphate kinase from Bacillus anthracis

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 3, 2008, Pages 244-260

  Byun, Youngjoo ^a   Vogel, Susan R ^b   Phipps, Andrew J ^b   Carnrot, Cecilia ^c   Eriksson, Staffan ^c   Tiwari, Rohit ^b   Tjarks, Werner ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

5 Modified thymidine based BaTMPK kinase inhibitors; Bacillus anthracis thymidine monophosphate kinase (BaTMPK)

Indexed keywords

1 [2,3 DIDEOXY 3 (HYDROXYMETHYL)BETA DEXTRO ERYTHROPENTOFURANOSYL]THYMINE; 1 [3 (AMINOMETHYL) 2,3 DIDEOXY BETA DEXTRO ERYTHRO PENTOFURANOSYL]THYMINE; THYMIDINE KINASE INHIBITOR; THYMIDINE PHOSPHATE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; GRAM POSITIVE BACTERIUM; LIPID SOLUBILITY; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; DRUG DESIGN; ENZYME INHIBITORS; NUCLEOSIDE-PHOSPHATE KINASE; THYMIDINE;

BACILLUS ANTHRACIS; POSIBACTERIA;

EID: 38949182374     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770701845238     Document Type: Article

References (41)

1. Borio, L.; Gronvall, L.; Kwik, G. Anthrax countermeasures: Current status and future needs. Biosecur. Bioterror. 2005, 3, 102-112.
2. Bryskier, A. Bacillus anthracis and antibacterial agents. Clin. Microbiol. Infect. 2002, 8, 467-478.
3. De Clercq, E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30, 115-133.
4. Galmarini, C.M.; Mackey, J.R.; Dumontet, C. Nucleoside analogues: Mechanisms of drug resistance and reversal strategies. Leukemia 2001, 15, 875-890.
5. Arner, E.S.; Eriksson, S. Mammalian deoxyribonuclease kinases. Pharmacol. Ther. 1995, 67, 155-186.
6. Van Daele, I.; Munier-Lehmann, H.; Hendrickx, P.M.S.; Marchal, G.; Chavarot, P.; Froeyen, M.; Qing, L.; Martins, J.C.; Van Calenbergh, S. Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase. Chem. Med. Chem. 2006, 1, 1081-1090.
7. Sorbera, L.A.; Castaner, J.; Rabasseda, X. Iclaprim: Antibacterial dihydrofolate reductase inhibitor. Drugs Future 2004, 29, 220-225.
8. Ferrari, S.; Costi, P.M.; Wade, R.C. Inhibitor specificity via protein dynamics insights from the design of antibacterial agents targeted against thymidylate synthase. Chem. Biol. 2003, 10, 1183-1193.
9. Torrents, E.; Sahlin, M.; Biglino, D.; Graeslund, A.; Sjoeberg, B.-M. Efficient growth inhibition of Bacillus anthracis by knocking out the ribonucleotide reductase tyrosyl radical. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 17946-17951.
10. Masters, P.A.; O'Bryan, T.A.; Zurlo, J.; Miller, D.Q.; Joshi, N. Trimethoprim-sulfamethoxazole revisited. Arch. Intern. Med. 2003, 163, 402-410.
11. Carnrot, C.; Vogel, S.R.; Byun, Y.; Wang, L.; Tjarks, W.; Eriksson, S.; Phipps, A.J. Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogs. Biol. Chem. 2006, 387, 1575-1581.
12. Vanheusden, V.; Munier-Lehmann, H.; Froeyen, M.; Dugue, L.; Heyerick, A.; De Keukeleire, D.; Pochet, S.; Busson, R.; Herdewijn, P.; Van Calenbergh, S. 3′-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. J. Med. Chem. 2003, 46, 3811-3821.
13. Bone, R.; Cheng, Y.C.; Wolfenden, R. Inhibition of adenosine and thymidylate kinases by bisubstrate analogs. J. Biol. Chem. 1986, 261, 16410-16413.
14. Orr, R.M.; Davies, L.C.; Stock, J.A.; Taylor, G.A.; Powles, R.L.; Harrap, K.R. Inhibition of human leukemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analogues. Biochem. Pharmacol. 1988, 37, 673-677.
15. Parang, K.; Cole, P.A. Designing bisubstrate analog inhibitors for protein kinases. Pharmacol. Ther. 2002, 93, 145-157.
16. Nguyen, C.; Kasinathan, G.; Leal-Cortijo, I.; Musso-Buendia, A.; Kaiser, M.; Brun, R.; Ruiz-Perez, L.M.; Johansson, N.G.; Gonzalez-Pacanowska, D.; Gilbert, I.H. Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target. J. Med. Chem. 2005, 48, 5942-5954.
17. Finking, R.; Neumueller, A.; Solsbacher, J.; Konz, D.; Kretzschmar, G.; Schweitzer, M.; Krumm, T.; Marahiel, M.A. Aminoacyl adenylate substrate analogues for the inhibition of adenylation domains of nonribosomal peptide synthetases. Chem Bio Chem 2003, 4, 903-906.
18. Forrest, A.K.; Jarvest, R.L.; Mensah, L.M.; O'Hanlon, P.J.; Pope, A.J.; Sheppard, R.J. Aminoalkyl adenylate and aminoacyl sulfamate intermediate analogues differing greatly in affinity for their cognate Staphylococcus aureus aminoacyl tRNA synthetases. Bioorg. Med. Chem. Lett. 2000, 10, 1871-1874.
19. Andres, C.J.; Bronson, J.J.; D'Andrea, S.V.; Deshpande, M.S.; Falk, P.J.; Grant-Young, K.A.; Harte, W.E.; Ho, H.-T.; Misco, P.F.; Robertson, J.G.; Stock, D.; Sun, Y.; Walsh, A.W. 4-Thiazolidinones: Novel inhibitors of the bacterial enzyme MurB. Bioorg. Med. Chem. Lett. 2000, 10, 715-717.
20. Guida, W.C.; Elliott, R.D.; Thomas, H.J.; Secrist, J.A.; III, Babu, Y.S.; Bugg, C.E.; Erion, M.D.; Ealick, S.E.; Montgomery, J.A. Structure-based design of inhibitors of purine nucleoside phosphorylase. 4. A study of phosphate mimics. J. Med. Chem. 1994, 37, 1109-1114.
21. Hamdouchi, C.; Zhong, B.; Mendoza, J.; Collins, E.; Jaramillo, C.; De Diego, J.E.; Robertson, D.; Spencer, C.D.; Anderson, B.D.; Watkins, S.A.; Zhang, F.; Brooks, H.B. Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases. Bioorg. Med. Chem. Lett. 2005, 15, 1943-1947.
22. Cosstick, R.; Jones, A.S.; Walker, R.T. Synthesis of some analogs of nucleoside 5′-triphosphates. Tetrahedron 1984, 40, 427-431.
23. Weaver, R.; Gilbert, I.H. The design and synthesis of nucleoside triphosphate isosteres as potential inhibitors of HIV reverse transcriptase. Tetrahedron 1997, 53, 5537-5562.
24. Bjoersne, M.; Classon, B.; Kvarnstroem, I.; Samuelseeon, B. Synthesis of mimics to thymidine triphosphate and 3′-deoxy-3′-fluorothymidine triphosphate. Nucleosides Nucleotides 1993, 12, 529-536.
25. Traxler, P.M.; Wacker, O.; Bach, H.L.; Geissler, J.F.; Kump, W.; Meyer, T.; Regenass, U.; Roesel, J.L.; Lydon, N. Sulfonylbenzoylnitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase. J. Med. Chem. 1991, 34, 2328-2337.
26. Marriott, J.; Jarman, M.; Neidle, S., Preparation of nucleoside phosphate mimics as enzyme inhibitors. WO/1997/040006, 1997.
27. Bloch, A. Coutsogeorgopoulos, C. Inhibition of protein synthesis by 5′-sulfamoyladenosine. Biochemistry (Mosc) 1971, 10, 4394-4398.
28. Jenkins, I.D.; Verheyden, J.P.H.; Moffatt, J.G. 4′-Substituted nucleosides. 2. Synthesis of the nucleoside antibiotic nucleocidin. J. Am. Chem. Soc. 1976, 98, 3346-3357.
29. Shuman, D.A.; Robins, M.J.; Robins, R.K. Synthesis of nucleoside sulfamates related to nucleocidin. J. Am. Chem. Soc. 1970, 92, 3434-3440.
30. Borman, S. A new way to fight bacteria. Chem. Eng. News 2005, 83, 13.
31. Ferreras, J.A.; Ryu, J.-S.; Di Lello, F.; Tan, D.S.; Quadri, L.E.N. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. Nat. Chem. Biol. 2005, 1, 29-32.
32. Nguyen, C.; Ruda, G.F.; Schipani, A.; Kasinathan, G.; Leal, I.; Musso-Buendia, A.; Kaiser, M.; Brun, R.; Ruiz-Perez, L.M.; Sahlberg, B.-L.; Johansson, N.G.; Gonzalez-Pacanowska, D.; Gilbert, I.H. Acyclic nucleoside analogues as inhibitors of plasmodium falciparum dUTPase. J. Med. Chem. 2006, 49, 4183-4195.
33. Hu, X.; Tierney, M.T.; Grinstaff, M.W. Synthesis and characterization of phenothiazine labeled oligodeoxynucleotides: Novel 2′-deoxyadenosine and thymidine probes for labeling DNA. Bioconjug. Chem. 2002, 13, 83-89.
34. Kolb, H.C.; Sharpless, K.B. The growing impact of click chemistry on drug discovery. Drug Discov. Today 2003, 8, 1128-1137.
35. Bock, V.D.; Hiemstra, H.; van Maarseveen, J.H. Cu(I)-catalyzed alkyne-azide click cycloadditions from a mechanistic and synthetic perspective. Eur. J. Org. Chem. 2005,, 51-68.
36. Himo, F.; Lovell, T.; Hilgraf, R.; Rostovtsev, V.V.; Noodleman, L.; Sharpless, K.B.; Fokin, V.V. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J. Am. Chem. Soc. 2005, 127, 210-216.
37. Monno, R.; Marcuccio, L.; Valenza, M.A.; Leone, E.; Bitetto, C.; Larocca, A.; Maggi, P.; Quarto, M. In vitro antimicrobial properties of azidothymidine (AZT). Acta Microbiol. Immunol. Hung. 1997, 44, 165-171.
38. Saito, H.; Tomioka, H. Thymidine kinase of bacteria: Activity of the enzyme in actinomycetes and related organisms. J. Gen. Microbiol. 1984, 130, 1863-1870.
39. Carnrot, C.; Wehelie, R.; Eriksson, S.; Boelske, G.; Wang, L.Molecular characterization of thymidine kinase from Ureaplasma urealyticum: Nucleoside analogues as potent inhibitors of mycoplasma growth. Mol. Microbiol. 2003, 50, 771-780.
40. Weber, K.; Osborn, M. Reliability of molecular weight determinations by dodecyl sulfatepolyacrylamide-gel electrophoresis. J. Biol. Chem. 1969, 244, 4406-4412.
41. Blondin, C.; Serina, L.; Wiesmueller, L.; Gilles, A.-M.; Barzu, O. Improved spectrophotometric assay of nucleosidemonophosphate kinase activity using the pyruvate kinase/lactate dehydrogenase coupling system. Anal. Biochem. 1994, 220, 219-221.